Publications by authors named "Yea Bin Cho"

Claim this Profile
I
Intrabody targeting of insulin receptor pY1150: A novel approach to modulate signaling pathways in colorectal cancer cells.
Ha Gyeong Shin, Na-Oh Yunn, Ji Woong Kim, Yea Bin Cho, Sung Ho Ryu

Cell Signal· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional epitope mapping of cell surface glucose-regulated protein 94: A combinatorial approach for therapeutic targeting.
Yea Bin Cho, In Young Ko, Hyun Jung Kim, Ji Woong Kim, Kyun Heo

Int J Biol Macromol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cell surface glucose-regulated protein 94 in gastric cancer with an anti-GRP94 human monoclonal antibody.
Hyun Jung Kim, Yea Bin Cho, Kyun Heo, Ji Woong Kim, Ha Gyeong Shin

BMB Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empowering SARS-CoV-2 variant neutralization with a bifunctional antibody engineered with tandem heptad repeat 2 peptides.
Ji Woong Kim, Ji Hyun Lee, Hyun Jung Kim, Kyun Heo, Yoonwoo Lee, Yea Bin Cho

J Med Virol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants.
Ji Woong Kim, Hyun Jung Kim, Kyun Heo, Yoonwoo Lee, Hui Jeong Jang, Yea Bin Cho, Hye Lim Choi

Front Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants.
Ji Woong Kim, Kyun Heo, Hyun Jung Kim, Youngki Yoo, Hyun-Soo Cho, Yea Bin Cho, Hye Lim Choi

Antiviral Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2.
Ji Woong Kim, Sung Won Min, Jichul Lee, Ha Gyeong Shin, Hye Lim Choi, Yea Bin Cho

Biomedicines· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An internalizing antibody targeting of cell surface GRP94 effectively suppresses tumor angiogenesis of colorectal cancer.
Yea Bin Cho, Ji Woong Kim, Kyun Heo, Hyun Jung Kim, Sumi Yun

Biomed Pharmacother· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. 2021, , 670.
Ji Woong Kim, Yea Bin Cho, Sukmook Lee

Cells· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy.
Ji Woong Kim, Yea Bin Cho, Sukmook Lee

Cells· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth.
Mee Hyun Jeoung, Taek-Keun Kim, Ji Woong Kim, Yea Bin Cho, Hee Jun Na

Biomolecules· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis